J0573 HCPCS Level II code: Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
J0573 is the HCPCS code for “Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0573Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
Short description: Bupren/nal 3.1 to 6mg bupren
HCPCS · United States
Notes for J0573
As CMS prints them, with any note J0573 takes from the headings above it.
Note
- CMS processing note 0127: PUBLICATION 100.2, CHAPTER 15, 50.1.
Medicare details
The indicators CMS publishes with J0573 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2015
Where J0573 sits
- 1J codesDrugs administered other than orally
- 2Active code J0573Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0573 mean?
J0573 is the HCPCS code for “Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0573?
CMS lists J0573’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0573
All J codesJ0561Injection, penicillin g benzathine, 100,000 unitsJ0565Injection, bezlotoxumab, 10 mgJ0567Injection, cerliponase alfa, 1 mgJ0570Buprenorphine implant, 74.2 mgJ0571Buprenorphine, oral, 1 mgJ0572Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphineJ0574Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphineJ0575Buprenorphine/naloxone, oral, greater than 10 mg buprenorphineJ0576Injection, buprenorphine extended-release (brixadi), 1 mgJ0577Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapyJ0578Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapyJ0582Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg